» Articles » PMID: 22705731

Vam3, a Derivative of Resveratrol, Attenuates Cigarette Smoke-induced Autophagy

Overview
Specialty Pharmacology
Date 2012 Jun 19
PMID 22705731
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To appraise the efficacy of Vam3 (Amurensis H), a dimeric derivative of resveratrol, at inhibiting cigarette smoke-induced autophagy.

Methods: Human bronchial epithelial cells were treated with cigarette smoke condensates, and a chronic obstructive pulmonary disease (COPD) model was established by exposing male BALB/c mice to cigarette smoke. The protein levels of the autophagic marker microtubule-associated protein 1A/1B-light chain 3 (LC3), Sirtuin 1 (Sirt1), and foxhead box O 3a (FoxO3a) were examined using Western blotting and Immunohistochemistry. LC3 punctae were detected by immunofluorescence. The levels of FoxO3a acetylation were examined by immunoprecipitation. The level of intracellular oxidation was assessed by detecting ROS and GSH-Px.

Results: Vam3 attenuated cigarette smoke condensate-induced autophagy in human bronchial epithelial cells, and restored the expression levels of Sirt1 and FoxO3a that had been reduced by cigarette smoke condensates. Similar protective effects of Vam3, reducing autophagy and restoring the levels of Sirt1 and FoxO3a, were observed in the COPD animal model. Additionally, Vam3 also diminished the oxidative stress that was induced by the cigarette smoke condensates.

Conclusion: Vam3 decreases cigarette smoke-induced autophagy via up-regulating/restoring the levels of Sirt1 and FoxO3a and inhibiting the induced oxidative stress.

Citing Articles

Natural autophagy modulators in non-communicable diseases: from autophagy mechanisms to therapeutic potential.

Xu T, Deng Y, Yu X, Li M, Fu Y Acta Pharmacol Sin. 2024; 46(1):8-32.

PMID: 39090393 PMC: 11697321. DOI: 10.1038/s41401-024-01356-y.


Molecular Mechanisms and the Interplay of Important Chronic Obstructive Pulmonary Disease Biomarkers Reveals Novel Therapeutic Targets.

Sharma G, Banerjee R, Srivastava S ACS Omega. 2023; 8(49):46376-46389.

PMID: 38107961 PMC: 10719921. DOI: 10.1021/acsomega.3c07480.


Stilbenes, a Versatile Class of Natural Metabolites for Inflammation-An Overview.

Al-Khayri J, Mascarenhas R, Harish H, Gowda Y, Lakshmaiah V, Nagella P Molecules. 2023; 28(9).

PMID: 37175197 PMC: 10180133. DOI: 10.3390/molecules28093786.


Autophagy in hepatic ischemia-reperfusion injury.

Mao B, Yuan W, Wu F, Yan Y, Wang B Cell Death Discov. 2023; 9(1):115.

PMID: 37019879 PMC: 10076300. DOI: 10.1038/s41420-023-01387-0.


SIRT1 as a Potential Therapeutic Target for Chronic Obstructive Pulmonary Disease.

Li S, Huang Q, He B Lung. 2023; 201(2):201-215.

PMID: 36790647 DOI: 10.1007/s00408-023-00607-9.


References
1.
Wood L, Wark P, Garg M . Antioxidant and anti-inflammatory effects of resveratrol in airway disease. Antioxid Redox Signal. 2010; 13(10):1535-48. DOI: 10.1089/ars.2009.3064. View

2.
Cohen H, Lavu S, Bitterman K, Hekking B, Imahiyerobo T, Miller C . Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis. Mol Cell. 2004; 13(5):627-38. DOI: 10.1016/s1097-2765(04)00094-2. View

3.
Vahtola E, Louhelainen M, Forsten H, Merasto S, Raivio J, Kaheinen P . Sirtuin1-p53, forkhead box O3a, p38 and post-infarct cardiac remodeling in the spontaneously diabetic Goto-Kakizaki rat. Cardiovasc Diabetol. 2010; 9:5. PMC: 2835668. DOI: 10.1186/1475-2840-9-5. View

4.
Lakhdar R, Denden S, Kassab A, Leban N, Knani J, Lefranc G . Update in chronic obstructive pulmonary disease: role of antioxidant and metabolizing gene polymorphisms. Exp Lung Res. 2011; 37(6):364-75. DOI: 10.3109/01902148.2011.580416. View

5.
Klionsky D, Cuervo A, Seglen P . Methods for monitoring autophagy from yeast to human. Autophagy. 2007; 3(3):181-206. DOI: 10.4161/auto.3678. View